Short interest in CRISPR Therapeutics AG (NASDAQ:CRSP) decreased during the last reporting period, falling from 19.39M to 18.15M. This put 24.11% of the company's publicly available shares short.

Short interest for CRISPR Therapeutics gives investors a sense of the degree to which investors are betting on the decline of CRISPR Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.57M shares traded per day, it would take 11.54 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.